Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Medtech research facility launched in Australia to help SMEs transition new discoveries from bench to bedside

Medtech research facility launched in Australia to help SMEs transition new discoveries from bench to bedside

Above image: ©CSIRO, Nick Pitsas

CSIRO, Monash University and Monash Health Translation Precinct (MHTP[1]) have launched a new translational medical technology (medtech) research facility called M2 to help small and medium enterprises (SMEs) in the sector transition new discoveries from the bench to prototyping, pre-clinical testing, industry evaluation and commercialisation.

This infrastructure is supported by the Science and Industry Endowment Fund (SIEF). It is expected to accelerate the achievement of breakthroughs in life-changing medicine, including medical devices, vaccines and cell therapies.

Australia has more than 500 companies working in the Medical Technologies and Pharmaceuticals (MTP) sector. Many of these are SMEs, which might not have the resources to make the expensive, time consuming transition from prototype to clinically tested product.  

In a video accompanying the press release, Dr. Gordon McPhee, Monash Health Translation Precinct explains, “The translational phase is something that’s often referred to as the “Valley of Death” for potential medical treatment. It’s where you are in a research environment, you have promising results that you need to trial in humans, in phase one clinical trials in humans and that step has traditionally been very expensive, with clean room space being very limited.”

M2 aims to bridge this gap for Australian businesses, by providing a ‘one stop shop’ and bringing together the best minds and technology together. M2 is expected to have all the things that a small manufacturing enterprise would need to develop products in the medtech sector.

In addition to expensive, important infrastructure, M2 will have people with extensive expertise in areas like polymers, surface coating technology, biofabrication and biocompatibility testing. SMEs can get all of that intellectual input in one place.

Officially launching the M2 precinct at CSIRO’s new Biomedical Materials Translation Facility (BMTF) in Clayton, Victoria, Minister for Industry, Innovation and Science Senator, Arthur Sinodinos, said, “From life-changing cochlear implants, to life-saving vaccines, world-first 3D printed bone and tissue replacements, Australia has an incredible track record when it comes to medical technologies and pharmaceuticals. M2 will help to accelerate development of technology like this, not only vital for the improvement of the lives of Australians facing medial challenges, but also leading to job and economic growth for Australia.”

“M2 leverages some of Australia’s best medtech expertise, experience and equipment. When a company comes to us we can use CSIRO and MHTP facilities to develop and analyse production scale prototypes, whilst the Monash Biomedical Imaging facility can provide advanced pre-clinical and clinical testing and imaging,” CSIRO Director of Manufacturing, Dr. Keith McLean added.

The press release says that MTP sector is expected to be worth almost $3 trillion by 2025, while $18 billion and 28,000 new jobs could be added to the Australian economy over the next eight years.

Monash University Provost and Senior Vice-President Professor Marc Parlange said, “This initiative will deliver real health benefits to all Australians. Our healthcare spending is expected to almost double to 16 per cent of GDP by 2040. Cheaper and more effective medical solutions are better for our health and Australia’s financial future.”

[1]MHTP is a collaborative initiative of Monash Health, Monash University and Hudson Institute of Medical Research.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.